Related Experiment Video
Updated: Sep 2, 2025

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
Published on: October 14, 2016
Clinical Profile and Predictors of Outcome in Children with Acute Fulminant Myocarditis Receiving Intensive Care: A
Muralidharan Jayashree1, Manisha Patil1, Govindappa Benakatti2
1Division of Pediatric Emergency and Intensive Care, Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Insights
Acute fulminant myocarditis in children is serious, but intravenous immunoglobulin (IVIG) treatment may improve survival. Multiorgan dysfunction independently predicts mortality in these critical pediatric cases.
Area of Science:
- Pediatric Cardiology
- Critical Care Medicine
- Immunology
Background:
- Acute myocarditis in children presents significant morbidity and mortality risks.
- Limited data exists on the efficacy of intravenous immunoglobulin (IVIG) for pediatric acute fulminant myocarditis (AFM).
Purpose of the Study:
- To analyze the clinical and treatment profiles of children with AFM.
- To identify predictors of outcome in pediatric AFM patients requiring intensive care.
- To evaluate the impact of IVIG on survival in this population.
Main Methods:
- Retrospective analysis of 120 children diagnosed with acute myocarditis between 2008 and 2018.
- Detailed review of clinical data, treatment interventions, and outcomes.
- Statistical analysis to identify factors associated with mortality and survival benefit.
Main Results:
- AFM affected 89 children, with 60.7% presenting with hypotension and a median ejection fraction of 25%.
- Mechanical ventilation (59.2%) and inotropic support (74.2%) were common intensive care interventions.
- Mortality was 17.5%, with fever, shock, acidosis, AKI, transaminitis, and multiorgan dysfunction syndrome (MODS) predicting poor outcomes.
- IVIG treatment was associated with significantly lower mortality (12.1% vs. 28.9%).
Conclusions:
- MODS is an independent predictor of mortality in pediatric AFM.
- IVIG treatment demonstrates a survival benefit in children with AFM.
- Aggressive management of complications like MODS is crucial for improving prognosis in pediatric AFM.
Abstract:
Acute myocarditis in children is associated with high morbidity and mortality, with limited data on intravenous immunoglobulin (IVIG) treatment and outcome. Our goal was to describe clinical, treatment profile, and predictors of outcome in children with acute fulminant myocarditis (AFM) receiving intensive care. Case records of 120 children with clinical diagnosis of acute myocarditis from January 2008 to December 2018 were analyzed retrospectively. AFM was seen in 89 (74.2%) children of which nearly two-thirds (54 [60.7%]) were hypotensive at admission. The median (interquartile range [IQR]) ejection fraction on echocardiography was 25 (18.5-36%). Eighty-two children (68.3%) received IVIG. Intensive care needs were mechanical ventilation ( n = 71; 59.2%) and inotrope support ( n = 89; 74.2%); median inotrope score being 30 (IQR: 20-55). Twenty-one children died (17.5%). Fever ( p = 0.004), arrhythmia ( p = 0.03), shock ( p = 0.015), higher inotrope score ( p = 0.0001), need for ventilation ( p = 0.025), acidosis ( p = 0.013), AKI ( p = 0.0001), transaminitis ( p = 0.0001), and multiorgan dysfunction ( p = 0.0001) were associated with mortality. The mortality was significantly less in IVIG treated group (12.1 vs. 28.9%; p = 0.02). On multiple logistic regression, MODS ( p = 0.002) was independent predictor of mortality while IVIG treatment ( p = 0.004) was favorably associated with survival. AFM complicated by multiorgan dysfunction carried a poor prognosis. IVIG was associated with survival benefit.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis IV: Nursing Management
Myocarditis III: Medical Management
Acute Coronary Syndrome III: Diagnostic Studies
Acute Kidney Injury III: Clinical Manifestations
Myocarditis I: Introduction

